The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
1
Evaluation and prediction of potential drug-drug interactions of linagliptin using in vitro cell culture methods.EBI
Nippon Boehringer Ingelheim
27
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment.EBI
Jacobio Pharmaceuticals
13
A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19.EBI
Pfizer
30
Discovery of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor for the Treatment of Heart Failure.EBI
Bristol Myers Squibb
1
Discovery of indoximod prodrugs and characterization of clinical candidate NLG802.EBI
Newlink Genetics
104
Imidazopyridazine compoundsBDB
Pfizer
5
ROR modulators and their usesBDB
Innov17